Related Experiment Video
Updated: May 3, 2026
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Integrated single-cell analysis reveals heterogeneity and therapeutic insights in osteosarcoma
Dongan He1, Xiaoqian Che1, Haiming Zhang1
1Department of Orthopaedics, Hangzhou Ninth People's Hospital, Hangzhou, China.
Abstract:
Osteosarcoma (OSA) is a primary bone malignancy characterized by its aggressive nature and high propensity for metastasis. Despite advancements in multimodal therapies, the clinical outcomes for OSA patients remain suboptimal, necessitating deeper molecular insights for improved therapeutic strategies. Here, we employed single-cell RNA sequencing (scRNA-seq) to elucidate the cellular heterogeneity and transcriptional dynamics of OSA tumors. Our study identified eleven distinct tumor cell subpopulations, including osteoblastic, chondroblastic, and myeloid lineages, each exhibiting unique transcriptional profiles associated with disease progression and metastasis. Epithelial-mesenchymal transition (EMT) emerged as a critical process driving aggressive phenotypes, supported by gene set enrichment analyses (GSVA) and transcription factor regulatory network analyses. Integration of copy number variation (CNV) data highlighted genomic alterations in osteoblastic and chondroblastic cells, implicating potential therapeutic targets. Furthermore, immune cell infiltration analyses revealed distinct immune profiles across OSA subtypes, correlating with tumor mutational burden (TMB) and clinical outcomes. Our findings underscore the complexity of OSA biology and provide a foundation for developing personalized treatment strategies targeting tumor heterogeneity and immune interactions.
Insights
Single-cell sequencing reveals diverse osteosarcoma (OSA) cell types and identifies epithelial-mesenchymal transition (EMT) as key to metastasis. This deepens understanding of OSA biology for targeted therapies.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Osteosarcoma (OSA) is an aggressive primary bone cancer with poor outcomes despite current treatments.
- Understanding OSA's molecular complexity is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate cellular heterogeneity and transcriptional dynamics in osteosarcoma using single-cell RNA sequencing (scRNA-seq).
- To identify molecular drivers of OSA progression and metastasis.
- To explore immune cell infiltration and its correlation with clinical outcomes.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) to analyze tumor cell populations.
- Gene Set Variation Analysis (GSVA) and transcription factor regulatory network analysis.
- Integration of copy number variation (CNV) data and immune cell infiltration analysis.
Main Results:
- Identified eleven distinct tumor cell subpopulations (osteoblastic, chondroblastic, myeloid) with unique transcriptional profiles.
- Epithelial-mesenchymal transition (EMT) identified as a critical driver of aggressive phenotypes and metastasis.
- Genomic alterations in osteoblastic and chondroblastic cells noted; distinct immune profiles correlated with tumor mutational burden (TMB) and outcomes.
Conclusions:
- OSA exhibits significant cellular heterogeneity, influencing disease progression and metastasis.
- EMT is a key mechanism in aggressive OSA phenotypes.
- Findings provide a basis for personalized treatments targeting tumor heterogeneity and immune interactions in osteosarcoma.
